Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET

Matthew S. Milak, Alin J. Severance, R. Todd Ogden, Jaya Prabhakaran, J.S. Dileep Kumar, Vattoly J. Majo, J. John Mann and Ramin V. Parsey
Journal of Nuclear Medicine April 2008, 49 (4) 587-596; DOI: https://doi.org/10.2967/jnumed.107.046540
Matthew S. Milak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alin J. Severance
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Todd Ogden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaya Prabhakaran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.S. Dileep Kumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vattoly J. Majo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. John Mann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramin V. Parsey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    (A) Fraction of plasma activity associated with unmetabolized 11C-CUMI-101 in baboon plasma during a single scan. Fitted line is estimated from the Hill model (1 − AtB/[tB + C]). (B) Total and metabolite-corrected plasma radioactivity. Fitted line represents the 3-exponential function fit to the data. Error bars represent weights calculated by the delta method.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Regional time–activity curves and corresponding least-squares minimized fits to 3 different models. (A) 2TCNI. (B) Basis pursuit. (C and D) LEGA (native and transformed space, respectively). CER = cerebellum; ACN = anterior cingulate; TEM = temporal cortex.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Modeling metrics comparing 2TCNI, basis pursuit, and LEGA models at 6 different scan durations. (A) PD. (B) WSMSS. (C) Variance. (D) ICC. (E) Identifiability. For all measures, medians are taken across all scans and all ROIs, for both subjects. (A) Error bars represent average deviation from the median. Asterisk in A indicates that the modeling of dorsal raphe did not converge for basis pursuit for the 100-min scan time (for a single study) and thus was left out of the analysis.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Mean percentage change (PD) in VT (A) and BPF (B) of 11C-CUMI-101 after blockade with 8-OH-DPAT and WAY-100635. Values were derived from the LEGA model with a 100-min scan duration. ACN = anterior cingulate; AMY = amygdala; CER = cerebellum; DRN = dorsal raphe; HIP = hippocampus; INS = insula; PFC = prefrontal cortex; TEM = temporal cortex.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    (First row) Sagittal, coronal, and axial parametric PET images of 11C-CUMI-101 BPF values in baboon brain. (Second and third rows): PET images after blockade by 8-OH-DPAT and WAY-100635, respectively. (Fourth row) Corresponding coregistered MR images. On the MR images, the hippocampus has been highlighted.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    Correlation plots of VT values across various modeling approaches including ROI-analysis vs. voxel-based analyses. (A) 2TCNI voxel vs. 2TCNI ROI (R2 = 0.97). (B) 2TCNI ROI vs. LEGA ROI (R2 = 0.97). (C) Basis pursuit ROI vs. LEGA ROI (R2 = 0.97). (D) 2TCNI voxel vs. LEGA ROI (R2 of 1.00). Line of identity has been added for reference. Data reflect all ROIs in all studies.

Tables

  • Figures
    • View popup
    TABLE 1

    Time Stability Data for 3 Models Tested

    2TCNIBasis pursuitLEGA
    ROIVTBPVTBPVTBP
    ACN9090110100100100
    AMY80801201009090
    DRN11011012012010090
    HIP1101101101109090
    INS80701201009090
    PFC11010090908080
    TEM707090909080
    • ACN = anterior cingulate; AMY = amygdala; DRN = dorsal raphe; HIP = hippocampus; INS = insula; PFC = prefrontal cortex; TEM = temporal cortex.

    • Numbers indicate the shortest scan duration for which the average VT and BPF values from all test–retest experiments for each ROI were between 95% and 105% of the average value, when using 120-min scan duration and also when SD of these percentages is <10%.

    • View popup
    TABLE 2

    Ranks of 3 Methods Used for Each Metric at 100-Minute Scanning Time*

    Metric2TCNILEGABasis
    PD213
    WSMSS213
    VAR213
    ICC222
    ID1N/A2
    • ↵* With 1 being the best of each criterion.

    • VAR = variance; ID = identifiability; N/A = not applicable.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 49 (4)
Journal of Nuclear Medicine
Vol. 49, Issue 4
April 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET
Matthew S. Milak, Alin J. Severance, R. Todd Ogden, Jaya Prabhakaran, J.S. Dileep Kumar, Vattoly J. Majo, J. John Mann, Ramin V. Parsey
Journal of Nuclear Medicine Apr 2008, 49 (4) 587-596; DOI: 10.2967/jnumed.107.046540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET
Matthew S. Milak, Alin J. Severance, R. Todd Ogden, Jaya Prabhakaran, J.S. Dileep Kumar, Vattoly J. Majo, J. John Mann, Ramin V. Parsey
Journal of Nuclear Medicine Apr 2008, 49 (4) 587-596; DOI: 10.2967/jnumed.107.046540
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 11C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to {alpha}1 Adrenoceptors in Brain
  • Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging
  • In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire